APP and Alzheimer disease: It was previously shown that expression of mir-107, a small noncoding RNA involved in the regulation of gene expression [244], is reduced in AD and may accelerate disease progression through the regulation of β-Site amyloid precursor protein-cleaving enzyme 1 (BACE1) [245,246], an endopeptidase that cleaves APP to generate Aβ [247,248].